| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |